Germline Genetics and Childhood Cancer: Emerging Cancer Predisposition Syndromes and Psychosocial Impacts
- 21 Downloads
Purpose of Review
Germline genetic variants contribute to a substantial proportion of cases of cancer in childhood. The purpose of this review is to describe two emerging pediatric cancer predisposition syndromes, including published surveillance protocols, as well as the psychological impacts related to childhood cancer predisposition.
DICER1 syndrome is pleotropic, predisposing to a variety of tumors and likely phenotypically broader than currently realized. Rhabdoid tumor predisposition syndrome carries a risk for development of aggressive malignancies occurring in nearly any tissue.
New pediatric hereditary cancer syndromes are likely to be identified as genetic evaluation evolves. Advantages and disadvantages of genetic testing and surveillance protocols need to be discussed with patients and families in a team-based approach, with the input of a genetic counselor holding expertise in pediatric cancer predisposition. Finally, literature on psychosocial impacts of hereditary cancer syndromes in pediatric patients is sparse, necessitating further research.
KeywordsCancer predisposition DICER1 Rhabdoid tumor predisposition SMARCB1 SMARCA4 Surveillance
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 2.•• Zhang J, Walsh MF, Wu G, et al. Germline mutations in predisposition genes in pediatric cancer. N Engl J Med. 2015;373(24):2336–46 This large-scale sequencing study involving 1120 children and adolescents with cancer identified germline mutations in cancer predisposition genes in 8.5% of patients. Further, family history did not predict an underlying predisposition syndrome for most patients. CrossRefGoogle Scholar
- 3.Parsons DW, Roy A, Yang Y, et al. 2016 Diagnostic yield of clinical tumor and germline whole-exome sequencing for children with solid tumors. JAMA Oncol. 2016;2(5):616–24.Google Scholar
- 5.•• Villani A, Shore A, Wasserman JD, et al. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study. Lancet Oncol. 2016;17(9):1295–305 This prospective, observational study showed feasibility of a long-term comprehensive surveillance protocol for patients with Li-Fraumeni syndrome as well as improved 5-year overall survival for those patients who chose to participate in the surveillance protocol. CrossRefGoogle Scholar
- 7.• Druker H, Zelley K, McGee RB, et al. Genetic counselor recommendations for cancer predisposition evaluation and surveillance in the pediatric oncology patient. Clin Cancer Res. 2017;23(13):e91–7 The 2016 AACR working group recommendations for pediatric cancer predisposition from a genetic counseling perspective are outlined in this article, with a focus on points of entry, the initial and subsequent genetic counseling sessions, testing processes, and the psychologic impact related to surveillance. CrossRefGoogle Scholar
- 17.•• Stewart DR, Best AF, Williams GM, et al. 2019 Neoplasm risk among individuals with a pathogenic germline variant in DICER1. J Clin Oncol. 2019;37(8):668–76. This article combines data from three large cohorts and provides the first quantitiate analysis of site-specific neoplasm risk as well as overall malignancy risk in non-proband DICER1 carriers. CrossRefGoogle Scholar
- 18.• Schultz KAP, Rednam SP, Kamihara J, et al. PTEN, DICER1, FH, and Their associated tumor susceptibility syndromes: clinical features, genetics, and surveillance recommendations in childhood. Clin Cancer Res. 2017;23(12):e76–82 The 2016 AACR working group recommendations for pediatric surveillance in PTEN , DICER1 , FH , and their associated predisposition syndromes are outlined in this article. CrossRefGoogle Scholar
- 23.• Foulkes WD, Kamihara J, Evans DGR, et al. Cancer surveillance in Gorlin syndrome and rhabdoid tumor predisposition syndrome. Clin Cancer Res. 2017;23(12):e62–7 The 2016 AACR working group recommendations for pediatric surveillance in Gorlin and rhabdoid tumor predisposition syndrome are outlined in this article. CrossRefGoogle Scholar
- 35.• Scollon S, Anglin AK, Thomas M, et al. A comprehensive review of pediatric tumors and associated cancer predisposition syndromes. J Genet Couns. 2017;26(3):387–434 This review highlights various tumor types arising in the pediatric population and cancer predisposition syndromes associated with those tumors, serving as a guide for recognition of these genes and conditions. CrossRefGoogle Scholar
- 41.The NCCN Clinical practice guidelines in oncology genetic/familial high-risk assessment: breast and ovarian (version 3.2019).Google Scholar
- 47.• Alderfer MA, Lindell RB, Viadro CI, et al. Should genetic testing be offered for children? The perspectives of adolescents and emerging adults in families with Li-Fraumeni syndrome. J Genet Couns. 2017;26(5):1106–15 This article documents genetic testing perspectives of adolescents and young adults in families with Li-Fraumeni syndrome. In general, all believed testing should be offered to children and was viewed as a way to learn about risk status, allow for disease prevention efforts, and reduce both uncertainty and anxiety. CrossRefGoogle Scholar
- 54.• Duffy KA, Grand KL, Zelley K, et al. Tumor screening in Beckwith-Wiedemann syndrome: parental perspectives. J Genet Couns. 2018;27(4):844–53 This article is the first to describe parental perspectives on tumor surveillance for children with Beckwith-Wiedemann syndrome and isolated hemihypertrophy. Parents reported overall decreased worry associated with screening and noted that screening did not increase either worry or create a burden. This highlights a need for educating families about tumor risk to facilitate informed decisions regarding tumor surveillance. CrossRefGoogle Scholar